We are building an industry-leading team that combines cutting-edge academic science and drug discovery expertise. Our Founders, Scientific Advisory Board members, and other advisors are leaders in their fields and broadly recognized for their world-class research and record of accomplishment in neuroscience, metabolism, gut biology, and molecular biology. Our management and scientific teams include experts in our core technology areas and individuals with deep drug discovery know-how and a proven ability to translate science to products.

Board of Directors

Amy Schulman

Polaris Partners

Adam Goulburn, Ph.D.

Lux Capital

Tim Kutzkey, Ph.D.

The Column Group

Nancy Thornberry

Chair, R&D, Kallyope

William Rieflin


Tom Maniatis, Ph.D.

Columbia University

Peter Hecht, Ph.D.

Tisento Therapeutics

Strategic Advisors

Tony Evnin, Ph.D.
Terry McGuire
Josh Wolfe

Lux Capital